Price To Earnings Ratio 67.00 | Sector PE 39.17 |
PB Ratio 11.21 | Sector PB 7.64 |
EPS 17.12 | Dividend Yield 3.09 |
Today's Volume 156.367 K | 5 Day Avg. Volume 154.876 K |
PEG Ratio 2.43 | Market Cap. ₹ 5,750.00 Cr. |
Thyrocare Technologies Limited is an Indian healthcare provider. The company has a Centralized Processing Laboratory (CPL) in Mumbai, India for esoteric testing and a regional processing laboratory in major cities in India and the rest of Asia. The company offers technologies such as chemiluminescence immunoassay (CLIA), enzyme-linked immunosorbent assay (ELISA), high-performance liquid chromatography (HPLC), capillary electrophoresis (CE), ion-selective electrodes (ISE), fluorescent flow cytometry, nephelometry, liquid photometry, chromatography mass spectrometry (LC-MS). , inductively coupled plasma mass spectrometry (ICP-MS) and cytogenetics. The company offers various tests such as Aarogyam X, Aarogyam XL, Aarogyam 1.1, Aarogyam 1.2 and Covid Antibody GT. It also offers thyroxine (T4), triiodothyronine (T3), thyroid stimulating hormone and complete vitamin profile tests.